IND Approval by US FDA for Phase II SAR-Bombesin trial
Filed with ASX · · 3 pages · English
Clarity Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Clarity Pharmaceuticals
- Notification regarding unquoted securities - CU6
- Presentation Jefferies Biotech Summit
- First patient treated in the prostate cancer imaging trial
- Clarity Half Yearly Report
- Half Year Accounts
Later from Clarity Pharmaceuticals
- Governance & Trading Policy Update
- Application for quotation of securities - CU6
- Imaging trial in prostate cancer opens for recruitment
- Paediatric neuroblastoma trial advances to cohort 3
- Recruitment opens for Phase II trial in Prostate Cancer
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals